3,929
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Blood pressure control with cilnidipine treatment in Japanese post-stroke hypertensive patients: The CA-ATTEND study

, , , , , , , & show all
Pages 225-234 | Received 21 Jun 2016, Accepted 28 Aug 2016, Published online: 27 Apr 2017

References

  • Hypertension. In Committee on the Japanese Guidelines for the Management of Stroke 2015, The Japan Stroke Society (eds), Japanese guidelines for the management of stroke 2015, KYOWA KIKAKU Ltd.: Tokyo, Japan, 2015, 24–26.
  • Shimamoto K, Ando K, Fujita T, et al. The japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 2014;37:253–390.
  • Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281–1357.
  • Nagahama S, Norimatsu T, Maki T, et al. The effect of combination therapy with an L/N-Type Ca(2+) channel blocker, cilnidipine, and an angiotensin II receptor blocker on the blood pressure and heart rate in Japanese hypertensive patients: an observational study conducted in Japan. Hypertens Res 2007;30:815–822.
  • Kario K, Ando SI, Kido H, et al. The effects of the L/N-Type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE. J Clin Hypertens 2013;15:133–142.
  • Kario K, Nariyama J, Kido H, et al. Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients. J Clin Hypertens (Greenwich) 2013;15:465–472.
  • Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
  • Imai Y, Otsuka K, Kawano Y, et al. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003;26:771–782.
  • Brown ML, Gersh BJ, Holmes DR, Bailey KR. Sundt TM 3rd. From randomized trials to registry studies: translating data into clinical information. Nat Clin Pract Cardiovasc Med 2008;5:613–620.
  • de Simone G, Izzo R, Verdecchia P. Are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument. Hypertension 2013;62:463–469.
  • Toschke AM, Gulliford MC, Wolfe CD, et al. Antihypertensive treatment after first stroke in primary care: results from the General Practitioner Research Database. J Hypertens 2011;29:154–160.
  • Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med 2009;2:30.
  • Liu L, Wang Z, Gong L, et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res 2009;32:1032–1040.
  • Gueyffier F, Boutitie F, Boissel JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med 1997;126:761–767.
  • PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 1995;108:710–717.
  • PROGRESS Collaborating Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
  • Stergiou GS, Siontis KC, Ioannidis JP. Home blood pressure as a cardiovascular outcome predictor: it’s time to take this method seriously. Hypertension 2010;55:1301–1303.
  • Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens 2012;30:449–456.
  • Daskalopoulou SS, Rabi DM, Zarnke KB, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2015;31:549–568.
  • Ohkubo T, Asayama K, Imai Y. The value of self-measured home blood pressure in predicting stroke. Expert Rev Neurother 2006;6:163–173.
  • Yasui D, Asayama K, Ohkubo T, et al. Stroke risk in treated hypertension based on home blood pressure: the Ohasama study. Am J Hypertens 2010;23:508–514.
  • Asayama K, Kikuya M, Schutte R, et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension 2013;61:61–69.
  • Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160–2236.
  • Towfighi A, Markovic D, Ovbiagele B. Consistency of blood pressure control after ischemic stroke: prevalence and prognosis. Stroke 2014;45:1313–1317.
  • Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan: where are we now? Circ J 2013;77:2226–2231.
  • Ohkubo T, Obara T, Funahashi J, et al. Control of blood pressure as measured at home and office, and comparison with physicians’ assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004;27:755–763.
  • Mori H, Ukai H, Yamamoto H, et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006;29:143–151.
  • Toyoda K, Ninomiya T. Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 2014;13:823–833.
  • Lee M, Saver JL, Chang K-H, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010;341:c4249.
  • Benavente OR, Coffey CS, Conwit R, et al. SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013;382:507–515
  • Arima H, Chalmers J, Woodward M, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006;24:1201–1208.
  • Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741–2748.
  • Wright JT Jr, Williamson JD, Whelton PK, et al. SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103–2116.
  • Hagino H, Sakamoto K, Harada A, et al. Nationwide one-decade survey of hip fractures in Japan. J Orthop Sci 2010;15:737–745.
  • Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009;169:1952–1960.
  • Klein D, Nagel G, Kleiner A, et al. Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&PP cohort. BMC Geriatr 2013;13:50.
  • Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–1707.
  • Butt DA, Mamdani M, Austin PC, et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med 2012;172:1739–1744.
  • Nakamura K, Takahashi S, Oyama M, et al. Incidence and risk factors associated with hip fracture in institutionalised elderly people in Japan. Age Ageing 2009;38:478–482.